Primary amoebic meningoencephalitis overview

Primary amoebic meningoencephalitis Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Primary Amoebic Meningoencephalitis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Primary amoebic meningoencephalitis overview On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Primary amoebic meningoencephalitis overview All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Primary amoebic meningoencephalitis overview
CDC on Primary amoebic meningoencephalitis overview
Primary amoebic meningoencephalitis overview in the news
Blogs on Primary amoebic meningoencephalitis overview
Directions to Hospitals Treating Primary amoebic meningoencephalitis
Risk calculators and risk factors for Primary amoebic meningoencephalitis overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Primary amoebic meningoencephalitis is a disease of the central nervous system caused by infection from Naegleria fowleri. Naegleria fowleri is a free-living ameboflagellate that invades the brain and meninges via the nasal mucosa and olfactory nerve to cause acute, fulminant hemorrhagic meningoencephalitis (primary amebic meningoencephalitis – PAM), primarily in healthy children and young adults with a recent history of exposure to warm fresh water. Initial signs and symptoms of PAM begin 1 to 14 days after infection and include sudden onset of headache, fever, nausea, vomiting, and stiff neck accompanied by positive Kernig’s and Brudzinski’s signs. In some cases, abnormalities in taste or smell, nasal obstruction and nasal discharge might be seen. Other symptoms might include photophobia, mental-state abnormalities, lethargy, dizziness, loss of balance, other visual disturbances, hallucinations, delirium, seizures, and coma. After the onset of symptoms, the disease progresses rapidly and usually results in death within 3 to 7 days. Although a variety of treatments have been shown to be active against amoebae in vitro and have been used to treat infected persons, most infections have still been fatal.